ENTRY       D00939                      Drug
NAME        Alendronate sodium (USP);
            Alendronate sodium hydrate (JP18);
            Binosto (TN);
            Fosamax (TN)
PRODUCT     BINOSTO (ASCEND Therapeutics U.S.)
            FOSAMAX (Organon LLC)
  GENERIC   ALENDRONATE (Hangzhou Minsheng Binjiang Pharmaceutical)
            ALENDRONATE (Marlex Pharmaceuticals)
            ALENDRONATE (Virtus Pharmaceuticals)
            ALENDRONATE SODIUM (A-S Medication Solutions)
            ALENDRONATE SODIUM (A-S Medication Solutions)
            ALENDRONATE SODIUM (A-S Medication Solutions)
            ALENDRONATE SODIUM (A-S Medication Solutions)
            ALENDRONATE SODIUM (A-S Medication Solutions)
            ALENDRONATE SODIUM (ANI Pharmaceuticals)
            ALENDRONATE SODIUM (Amneal Pharmaceuticals of New York LLC)
            ALENDRONATE SODIUM (Aurobindo Pharma Limited)
            ALENDRONATE SODIUM (Cipla USA)
            ALENDRONATE SODIUM (DIRECT RX)
            ALENDRONATE SODIUM (Direct_Rx)
            ALENDRONATE SODIUM (EXELAN PHARMACEUTICALS)
            ALENDRONATE SODIUM (Hikma Pharmaceuticals USA)
            ALENDRONATE SODIUM (NorthStar Rx LLC)
            ALENDRONATE SODIUM (Preferred Pharmaceuticals)
            ALENDRONATE SODIUM (Preferred Pharmaceuticals)
            ALENDRONATE SODIUM (Proficient Rx LP)
            ALENDRONATE SODIUM (REMEDYREPACK)
            ALENDRONATE SODIUM (RedPharm Drug)
            ALENDRONATE SODIUM (Rising Pharmaceuticals)
FORMULA     C4H12NO7P2. 3H2O. Na
EXACT_MASS  325.0304
MOL_WEIGHT  325.1237
CLASS       Musculo-skeletal system agent
             DG03232  Osteoporosis agent
              DG01600  Bisphosphonate
REMARK      Therapeutic category: 3999
            ATC code: M05BA04
            Chemical structure group: DG00783
            Product (DG00783): D00939<JP/US>
            Product (mixture): D10841<US>
EFFICACY    Antiresorptive, Osteoporosis agent, Farnesylpyrophosphate synthetase inhibitor
  DISEASE   Osteoporosis [DS:H01593]
            Glucocorticoid-induced osteoporosis [DS:H01709]
            Paget's disease of bone [DS:H00437]
COMMENT     Bisphosphonate
TARGET      FDPS [HSA:2224] [KO:K00787]
  PATHWAY   hsa00900(2224)  Terpenoid backbone biosynthesis
INTERACTION  
STR_MAP     map07047  Osteoporosis drugs
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             M MUSCULO-SKELETAL SYSTEM
              M05 DRUGS FOR TREATMENT OF BONE DISEASES
               M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
                M05BA Bisphosphonates
                 M05BA04 Alendronic acid
                  D00939  Alendronate sodium (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Metabolic Bone Disease Agents
              Bisphosphonates
               Alendronate
                D00939  Alendronate sodium (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             3  Agents affecting metabolism
              39  Other agents affecting metabolism
               399  Miscellaneous
                3999  Others
                 D00939  Alendronate sodium (USP); Alendronate sodium hydrate (JP18)
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00783  Alendronic acid
                 D00939  Alendronate sodium
            Drug classes [BR:br08332]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               D00939  Alendronate sodium
            Target-based classification of drugs [BR:br08310]
             Enzymes
              Transferases (EC2)
               Alkyl/Aryl transferases
                FDPS
                 D00939  Alendronate sodium (USP) &lt;JP/US&gt;
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00939  Alendronate sodium hydrate
              D00939  Alendronate sodium tablets
              D00939  Alendronate sodium injection
            Drug groups [BR:br08330]
             Musculo-skeletal system agent
              DG03232  Osteoporosis agent
               DG01600  Bisphosphonate
                DG00783  Alendronic acid
DBLINKS     CAS: 121268-17-5
            PubChem: 7848002
            ChEBI: 2566
            LigandBox: D00939
            NIKKAJI: J1.639.609E J2.222.290B
ATOM        18
            1   O0  O    29.9425  -25.6767
            2   Z   Na   26.3872  -22.7066 #+
            3   P1b P    22.2600  -24.5000
            4   C1d C    23.5900  -24.5000
            5   C1b C    23.5900  -22.6100
            6   O1a O    23.5900  -25.8300
            7   P1b P    24.9900  -24.5000
            8   O1c O    26.3200  -24.5000 #-
            9   O1c O    20.8600  -24.5000
            10  O1c O    22.2600  -23.1000
            11  O1c O    24.9900  -23.1000
            12  C1b C    24.7800  -21.9800
            13  C1b C    24.7800  -20.5800
            14  N1a N    25.9700  -19.8800
            15  O1c O    22.2600  -25.8300
            16  O1c O    24.9900  -25.8300
            17  O0  O    29.9425  -25.6767
            18  O0  O    29.9425  -25.6767
BOND        13
            1     3   4 1
            2     4   5 1
            3     4   6 1
            4     4   7 1
            5     7   8 1
            6     3   9 1
            7     3  10 2
            8     7  11 2
            9     5  12 1
            10   12  13 1
            11   13  14 1
            12    3  15 1
            13    7  16 1
BRACKET     1    28.2800  -26.7400   28.2800  -24.7800
            1    30.3100  -24.7800   30.3100  -26.7400
            1  3
  ORIGINAL  1    1
  REPEAT    1   17  18
///
